Tag: Resp
Nexcella Announces Positive NXC-201 Clinical Results at ASGCT: 100% Overall Resp…...
8 AL Amyloidosis patients relapsed/refractory to DARZALEX®-based regimens were treated with CAR-T NXC-201100% (8/8) overall response rate and 63% (5/8) complete response (MRD...